Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01093339
Other study ID # SLEEP DEPRIVATION
Secondary ID
Status Completed
Phase N/A
First received March 24, 2010
Last updated August 18, 2010
Start date August 2006
Est. completion date March 2010

Study information

Verified date August 2010
Source Southern Arizona VA Health Care System
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine if sleep deprivation results in increased esophageal acid exposure in healthy controls and gastroesophageal reflux disease (GERD) patients.


Description:

To determine if increased esophageal acid exposure is mediated by altering appetite regulation. To assess if there is any relationship between sleep deprivation and the serum level of TNF-alfa (a protein that can be elevated in inflammation).


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date March 2010
Est. primary completion date March 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Male/Female - 18-80

- 2 or more episodes of heartburn a week for last 3 months

Exclusion Criteria:

- Previous upper GI surgery

- Underlying co-morbidity

- Narcotic medications

- Psychotropic's and Benzodiazapines medications

- Hx of psychological abnormalities

- Hx of ETOH in previous 6 mos.

- Diabetes Mellitus

- Neuropathy

- Seizures

- Sleep Apnea

- Co-morbidity that interfere w/sleep

- Women who are pregnant, or childbearing yrs, not on BC

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Locations

Country Name City State
United States SArizonaVAHCS Tucson Arizona

Sponsors (1)

Lead Sponsor Collaborator
Southern Arizona VA Health Care System

Country where clinical trial is conducted

United States,